EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparison of Sevoflurane and Desflurane on Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation: A Propensity Score-Matched Analysis

Hyeun-Joon Bae iD, Sa-Jin Kang iD, Kyoung-Sun Kim iD, Hye-Mee Kwon, In-Gu Jun iD, Jun-Gol Song iD, Gyu-Sam Hwang iD

Medicina · 03.05.2026 · 62 (5) · 876

DOI: 10.3390/medicina62050876 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Medicina, online erschienen am 03.05.2026. Verfasst von Hyeun-Joon Bae und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul …. Hauptthemen laut MEDLINE: Desflurane, Sevoflurane, Carcinoma, Hepatocellular, Liver Transplantation. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives: While liver transplantation (LT) is a definitive treatment for hepatocellular carcinoma (HCC), tumor recurrence remains a major clinical concern. Although volatile anesthetics influence oncological outcomes, direct comparison between sevoflurane and desflurane remains scarce. This study aimed to investigate the impact of the recipient’s volatile anesthetic choice (sevoflurane vs. desflurane) on HCC recurrence following living donor liver transplantation (LDLT). Materials and Methods: This retrospective cohort study included adult patients who underwent LDLT for HCC. Patients were then divided into sevoflurane and desflurane groups, and propensity score matching (PSM) was used to balance baseline variables. The primary outcome was HCC recurrence, and the secondary outcomes were overall survival (OS) and postoperative C-reactive protein (CRP) levels as a marker for the postoperative systemic inflammatory response.

Results

After PSM, 373 matched pairs (n = 746) were analyzed. HCC recurrence was significantly higher in the sevoflurane group compared to the desflurane group (19.6% vs. 13.1%, p = 0.023). Kaplan–Meier analysis also demonstrated that cumulative recurrence of HCC was significantly higher in recipients who received sevoflurane anesthesia than in those who received desflurane (log-rank p = 0.0018). In multivariate Cox proportional hazards regression analysis, the use of sevoflurane for anesthesia maintenance was an independent risk factor forHCC recurrence (Hazard Ratio, 1.66; 95% Confidence Interval, 1.15–2.39; p = 0.007). Regarding OS, no significant difference was observed between the two groups (log-rank p = 0.1123). Postoperative CRP levels were significantly higher in the sevoflurane group compared to the desflurane group, suggesting a more intense systemic inflammatory response associated with sevoflurane maintenance.

Conclusions

For HCC patients undergoing LDLT, anesthesia maintenance with desflurane is associated with a reduced risk of tumor recurrence compared to sevoflurane, without a significant impact on overall survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DesfluraneSevofluraneCarcinoma, HepatocellularLiver TransplantationLiver NeoplasmsNeoplasm Recurrence, LocalHumansMaleFemalePropensity ScoreRetrospective StudiesMiddle AgedLiving DonorsAdultAnesthetics, InhalationCohort StudiesKaplan-Meier EstimateProportional Hazards Models

Stichwörter der Autor:innen

hepatocellular carcinomaliving donor liver transplantationtumor recurrencevolatile anesthetics

Substanzen

DesfluraneSevofluraneAnesthetics, Inhalation

Autor:innen und Institutionen

  • Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Republic of Korea.

ORCID-Profile: Hyeun-Joon Bae, Sa-Jin Kang, Kyoung-Sun Kim, In-Gu Jun, Jun-Gol Song, Gyu-Sam Hwang

Zitieren

APA

Bae, H. J., Kang, S. J., Kim, K. S., Kwon, H. M., Jun, I. G., Song, J. G., & Hwang, G. S. (2026). Comparison of Sevoflurane and Desflurane on Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation: A Propensity Score-Matched Analysis. Medicina, 62(5), 876. https://doi.org/10.3390/medicina62050876

Vancouver

Bae HJ, Kang SJ, Kim KS, Kwon HM, Jun IG, Song JG, et al. Comparison of Sevoflurane and Desflurane on Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation: A Propensity Score-Matched Analysis. Medicina. 2026;62(5):876. doi:10.3390/medicina62050876

BibTeX
@article{Bae2026,
  author = {Bae, Hyeun-Joon and Kang, Sa-Jin and Kim, Kyoung-Sun and Kwon, Hye-Mee and Jun, In-Gu and Song, Jun-Gol and Hwang, Gyu-Sam},
  title = {Comparison of Sevoflurane and Desflurane on Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation: A Propensity Score-Matched Analysis},
  journal = {Medicina},
  year = {2026},
  volume = {62},
  number = {5},
  pages = {876},
  doi = {10.3390/medicina62050876}
}
Kostenlos starten →